PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,000 | -11.1% | 2,800 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | +28.6% | 2,800 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | +16.7% | 2,800 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 2,800 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -10.0% | 2,800 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -28.6% | 2,800 | 0.0% | 0.00% | – |
| Q3 2015 | $14,000 | -22.2% | 2,800 | 0.0% | 0.00% | – |
| Q2 2015 | $18,000 | -10.0% | 2,800 | 0.0% | 0.00% | – |
| Q1 2015 | $20,000 | -9.1% | 2,800 | 0.0% | 0.00% | – |
| Q4 2014 | $22,000 | +4.8% | 2,800 | 0.0% | 0.00% | – |
| Q3 2014 | $21,000 | -22.2% | 2,800 | 0.0% | 0.00% | – |
| Q2 2014 | $27,000 | +17.4% | 2,800 | 0.0% | 0.00% | – |
| Q1 2014 | $23,000 | -4.2% | 2,800 | 0.0% | 0.00% | – |
| Q4 2013 | $24,000 | +9.1% | 2,800 | 0.0% | 0.00% | – |
| Q3 2013 | $22,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q2 2013 | $22,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |